New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Daré Bioscience, Inc.
DARE
Shape
US Flag

NASDAQ

EPS improving

EPS improving

29M

Biotechnology

Next Earning date - 14 Nov 2024

29M

Biotechnology

Next Earning date - 14 Nov 2024

3.35USD
Shape-0.02 ( -0.59%)
favorite-chart

Relative Strenght

16
favorite-chart

Volume Buzz

25%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

56%

Quote Panel

Shape
Updated October 12, 2024
1W 1.52 % 1M 1.21 % 3M -0.89 % 1Y -39.31 %

Key Metrics

Shape
  • Market Cap

    28.63M


  • Shares Outstanding

    8.55M


  • Share in Float

    8.41M


  • Dividende

    0


  • Earning Date

    14 Nov 2024


  • Price Target

    3.35


  • Average Volume

    38767


  • Beta

    1.385


  • Range

    3.05-7.56


  • Industry

    Biotechnology


  • Website

    https://www.darebioscience.com


  • Sector

    Healthcare


Fundamentals

Shape

6.32x

P/E Ratio

10.08x

P/S Ratio

10.55x

P/B Ratio

1.8

Debt/Equity

-253.6%

Net Margin

$32.3

EPS

How DARE compares to sector?

P/E Ratio

Relative Strength

Shape

DARE

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$23M

Shape100203%

2025-Revenue

$2.22

Shape-245%

2025-EPS

$5M

Shape162%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.08
vs -0.18

Q4.22

arrow
arrow

N/A

-0.19
vs -0.18

Q1.23

arrow
arrow

N/A

-0.09
vs -0.10

Q2.23

arrow
arrow

N/A

-0.10
vs 0

Q3.23

arrow
arrow

N/A

-0.09
vs -0.08

Q4.23

arrow
arrow

N/A

-0.06
vs -0.19

Q1.24

arrow
arrow

N/A

-0.84
vs -0.09

Q2.24

arrow
arrow

+1620%

1.52
vs -0.10

Q3.24

arrow
arrow

N/A

-0.69
vs -0.09

Q4.24

arrow
arrow

N/A

-0.50
vs -0.06

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

10B  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

-100%

NA  vs 10M

Q3.23

arrow
arrow

NA

1M  vs NA

Q4.23

arrow
arrow

-100%

1.8M  vs 10B

Q1.24

arrow
arrow

NA

9.3K  vs NA

Q2.24

arrow
arrow

NA

22.4K  vs NA

Q3.24

arrow
arrow

+4%

1M  vs 1M

Q4.24

arrow
arrow

-22%

1.4M  vs 1.8M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-26%

-0.26
vs 0.01

Q4.22

arrow
arrow

-143%

-1.43
vs -0.26

Q1.23

arrow
arrow

-162%

-1.62
vs -1.43

Q2.23

arrow
arrow

+322%

3.22
vs -1.62

Q3.23

arrow
arrow

+363%

3.63
vs 3.22

Q4.23

arrow
arrow

+100%

1
vs 3.63

Q1.24

arrow
arrow

+61%

0.61
vs 1

Q2.24

arrow
arrow

+483%

4.83
vs 0.61

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

29

29
vs 35

-17%

Q4.22

arrow
arrow

29

29
vs 29

NA

Q1.23

arrow
arrow

28

28
vs 29

-3%

Q2.23

arrow
arrow

26

26
vs 28

-7%

Q3.23

arrow
arrow

29

29
vs 26

12%

Q4.23

arrow
arrow

33

33
vs 29

14%

Q1.24

arrow
arrow

35

35
vs 33

6%

Q2.24

arrow
arrow

24

24
vs 35

-31%

Earnings Growth

Latest News